S&P 5007,765.36▼0.5% Nasdaq27,193.34▼1.2% Dow51,231.64▲0.1% Russell 2K2,794.13▲0.0% 10-Yr5.23%−5bp VIX15.41+0.33 WTI$91.10▲3.2% Gold$4,157.80▲0.4% EUR/USD1.122▼0.3% BTC$81,907▼1.4% Nikkei70,036▼0.9%
At close · Thu, Oct 8, 2026
Daily Market Updates.

US Markets

Home›US Markets›M&A & Deals›AstraZeneca and Bristol-Myers Squibb tie-up talks roil…

AstraZeneca and Bristol-Myers Squibb tie-up talks roil shares

Bristol-Myers Squibb stock rose while AstraZeneca shares fell as reports of potential deal discussions spread.

Reported · Written up by our desk · M&A & Deals

MarketWatch reports that shares of AstraZeneca and Bristol-Myers Squibb moved sharply on Monday amid reports of tie-up talks.

According to MarketWatch, Bristol-Myers Squibb was jumping while AstraZeneca was slumping.

The report notes analysts are focused on the rationale for a potential combination between the two pharmaceutical companies, beyond the immediate stock reaction.

← Newer storyBithumb lays out roadmap for 2028 IPO after K-IFRS shift

More like this

US MarketsSEC proposals would shift power away from retail investors
US MarketsApple launches HomeView smart home hub with upgraded Siri AI
US MarketsIthaca Holdings to buy Bumble for $1.3 billion
US MarketsPoundland in talks with buyers as management seeks buyout
US MarketsTFG London investigates cyber incident affecting Phase Eight, Hobbs and Whistles

Sources

MarketWatchAstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
MarketWatchAstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.